Cresset Asset Management, LLC Uro Gen Pharma Ltd. Transaction History
Cresset Asset Management, LLC
- $17.3 Billion
- Q4 2024
A detailed history of Cresset Asset Management, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 16,716 shares of URGN stock, worth $165,822. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,716
Previous 16,716
-0.0%
Holding current value
$165,822
Previous $212,000
16.04%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding URGN
# of Institutions
137Shares Held
36.2MCall Options Held
57.7KPut Options Held
9.8K-
Rtw Investments, LP New York, NY3.83MShares$38 Million0.67% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.93MShares$29 Million0.06% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$22.8 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$21.8 Million0.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.75MShares$17.4 Million0.03% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $226M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...